OGT Expands Custom NGS Cancer Panel Content and Readies Enhanced Software for Release
The expanded SureSeq myPanel next-generation sequencing custom cancer panel now covers 120 fully optimized cancer-related genes.
Read MoreSearch Results for: prostate cancer
Circulating Tumor Cells Help to Stage Metastatic Breast Cancer
A study presented at the annual meeting of the American Society of Clinical Oncology added to evidence supporting the clinical utility of the Cellsearch system for CTC testing.
Read More
Protagen and UCSF to Study Better Immunoprofiling of Cancer Patients
With improved immunoprofiling and patient stratification, cancer immunotherapies can be very powerful, and provide novel opportunities for the treatment of cancer.
Read MorePeople with False-Positive Cancer Screening Results May Be More Likely to Receive Future Screening
False-positive results may affect individuals’ willingness to continue screening for cancer in the future, causing them to be either more diligent or more reluctant about getting screened.
Read More
FDA Authorizes 23andMe Direct-to-Consumer BRCA Cancer Test
The test from 23andMe is the first to report on three specific BRCA1/BRCA2 breast cancer gene mutations that are most common in people of Ashkenazi Jewish descent.
Read More